2010

March 2, 2010
Chemosensitivity/Resistance Assay Included As Part of the NCCN Principles of Chemotherapy

Feruary 3, 2010
Patients, Physicians Rely on ChemoFx® to Support Their Cancer Treatment Decisions

January 21, 2010
Precision Therapeutics CEO Presents at J.P. Morgan 28th Annual Healthcare Conference

January 21, 2010
Precision Therapeutics to Present at Jeffries 2010 Global Healthcare Services Conference

2009

November 2009
Precision Quarterly Newsletter

October 2, 2009
Precision Therapeutics heading to Pittsburgh's Lawrenceville neighborhood

September 21, 2009
Precision Therapeutics President and CEO Sean McDonald Recipient of 2009 Pacesetter Award

September 10, 2009
Pittsburgh-based tech firm clarifies approval
process

September 2009
INC. Magazine names Precision Therapeutics one of the fastest growing private companies

June 2009
Precision Quarterly Newsletter

May 18, 2009
OCNA sends an open letter to the Payer community

May 2009
ChemoFx® offers hope to cancer patients

March 1, 2009
Precision's Quarterly Newsletter

Archived News